MLM
ABBV icon

Mount Lucas Management’s AbbVie ABBV Stock Holding History

Mount Lucas Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-19,370
Closed -$3.09M – 140
2023
Q1 		$3.09M Buy
19,370
+856
+5% +$131K 0.81% 30
2022
Q4 		$2.99M Sell
18,514
-131
-0.7% -$20.1K 0.98% 32
2022
Q3 		$2.5M Sell
18,645
-281
-1% -$40.3K 0.86% 34
2022
Q2 		$2.9M Buy
+18,926
New +$2.89M 0.97% 21

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mount Lucas Management's ABBV Position: Q2 2023 in Review

Mount Lucas Management sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 19,370 shares — an estimated $3.09M sold.

Mount Lucas Management first reported a position in ABBV in Q2 2022 and held it in 4 quarters. The position peaked at $3.09M in Q1 2023. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • Mount Lucas Management reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • Mount Lucas Management sold 19,370 AbbVie shares in Q2 2023, an estimated $3.09M.
  • Mount Lucas Management first reported a position in AbbVie in Q2 2022 and held it in 4 quarters.
  • Mount Lucas Management's AbbVie position peaked at $3.09M in Q1 2023.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Mount Lucas Management's 13F filing for Q2 2023, filed 14 Aug 2023.